Funicular Fund, LP's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Apr 20, 2022
- Accession no.
- 0000921895-22-001318
- Filed
- Apr 20, 2022, 7:43 PM ET
- Trade date
- Apr 18-19, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $21.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Funicular Fund, LPCIK 0001752618 | Other: See Footnote 1 |
| Ma-Weaver JacobCIK 0001922140 | Other: See Footnote 1 |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2022 | Common Stock | PPurchaseAcquired | +9,119 | $2.31F2 | +$21,080.39 | 2,180,219 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2022 | Common Stock | SSaleDisposed | −700,000 | $64.00F4 | −$448,000 | 7,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.3050 to $2.3150, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The Fund wrote 7,000 European-Style put option contracts expiring in December 2022 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The price of the premium received by the Fund for each contract includes brokerage commissions.
Referenced by the price of 1 transaction in Table II.